Our partners from UBT were invited to participate in the 2nd International Conference on Young Women’s Breast Cancer and Health , held on 15-16 November 2025 in New Delhi, India. The event brought together healthcare professionals, researchers, and advocates from around the world to discuss the latest developments in breast cancer care and women’s health, with a special focus on younger women. During the conference, UBT Co-Founder Gianluigi Tiberi presented the talk “Lessons from Global Models: Breast Test Using Radiofrequency Signals” , highlighting the potential of MammoWave® as a safe and accessible breast test that could support prevention and expand screening opportunities. The conference focused on encouraging research that can make a real difference in clinical practice and help address the specific challenges faced by younger women affected by breast cancer.

LSBU and UBT participated in the 1st edition of the International Conference on Medical Microwave Imaging Applications (ICMWIA), held on 3-5 February 2026, in Lisbon, Portugal, and organised within the European 3BAtwin initiative. During the conference, the teams presented their work on “Exploiting Phase Information from Microwave Imaging for Breast Density Classification: A Deep Learning Approach” which explored how information from microwave imaging can help classify breast density using artificial intelligence. They presented results obtained with a deep learning model that can be used to distinguishing between high- and low-density breast tissue, highlighting the potential of microwave imaging to support breast cancer risk assessment and improve AI-based screening approaches.

Also, in ICMWIA, SESCAM joined LSBU and UBT presenting the study “Microwave Imaging for Breast Cancer Screening: Interim Analysis Results from MammoScreen Clinical Trials”. In this work, they shared interim results from the MammoScreen Project clinical trial, obtained from the analysis of data gathered from 3,000 volunteers across nine hospitals in five European countries. The presentation highlighted the progress of the MammoWave® AI model in detecting suspicious breast findings, showing significant improvements after combining machine learning and statistical approaches. The promising results obtained with the updated model demonstrate the potential of microwave imaging for future breast cancer screening programmes.

UBT attended the European Congress of Radiology 2026 (ECR 2026), held from 4-8 March in Vienna, Austria. Organised by the European Society of Radiology, ECR is one of the world’s leading radiology conferences, bringing together experts and researchers from across the medical imaging field. UBT´s Gianluigi Tiberi contributed to the session “RPS 1002 – Breast Cancer Screening: Technology, Tools, and Trends”, sharing the project´s latest scientific progress with the oral presentation “Radiofrequency-Based Imaging for Breast Screening: Interim Analysis Results from MammoScreen Clinical Trial”.

SESCAM participated in the XIV Jornadas Nacionales SEDISA (embed link: ), held on 15-17 April 2026 in Toledo, Spain, which were organised by the Sociedad Española de Directivos de la Salud (SEDISA), one of Spain’s leading healthcare management organisations. The conference brought together hospital managers, healthcare leaders, and experts to discuss innovation, technology and the future of healthcare management under the theme “Healthcare Management in the New Era: Strategy, Innovation and Technology.” During the event, the SESCAM team presented the talk “Microwave Imaging for Breast Cancer Detection: Technological Advances, Clinical Results and Future Challenges”, where they shared the latest developments from the MammoScreen Project and discussed the potential of microwave imaging in the future of breast cancer screening.

The Institute for Research and Innovation in Health (i3S) hosted the Porto Cancer Meeting, from 22-24 April 2026 in Porto, Portugal, as a joint event with the PREVENTABLE project. The meeting gathered leading experts in cancer research, clinical practice and patient advocacy to discuss recent advances and ongoing challenges in the field. A Speaker Spotlight featured Tamara Milagre, founder and president of the patient association EVITA, one of the MammoScreen Project´s partners. Her work spans initiatives within ERN GENTURIS, patient education, cancer registries, and international efforts in genomic medicine. A prominent advocate for hereditary cancer awareness and patient empowerment, she emphasized the importance of collaboration between patients, clinicians and researchers within EU funded projects.

SESCAM participated in the 38 Congreso Nacional de la SERAM, organized by the Sociedad Española de Radiología Médica (SERAM), held from 20-23 May 2026 in Valencia, Spain. The congress brought together radiology professionals and experts to discuss the latest developments in medical imaging, healthcare management and innovation in Spain. Contributing to the session “Process Engineering, Engineers in Radiology” within the area of “Safety, Management and Quality”, Dr. Daniel Sanchez-Bayuela presented the talk “From Clinical Research to Healthcare Innovation: The Role of the Biomedical Engineer in Radiology”, highlighting how biomedical engineering can help transform radiology processes by connecting clinical research, technological innovation, and everyday healthcare practice.

The magazine La Vida en Rosa featured an interview with our SESCAM partners about the MammoScreen Project and its research into the use of low-power radiofrequency signals and artificial intelligence for breast cancer screening. The interview highlighted the progress made with MammoWave®, including two completed clinical studies and the ongoing large-scale European clinical trial funded by the EU’s Horizon Europe Cancer Mission. The article also emphasized the importance of multidisciplinary collaboration to ensure that innovation responds to real clinical needs while keeping patients at the center of care. The interview highlighted the growing role of biomedical engineers in helping integrate AI into healthcare and shaping the future of multidisciplinary hospital teams. The MammoScreen Project thanks La Vida en Rosa for helping raise awareness of breast cancer research and innovation.

EVITA continues to raise awareness about breast cancer in young women, joining the voice of the Breast Cancer in Young Women Foundation (BCYWF) as an ambassador for hereditary breast cancer awareness. This collaboration highlights the specific challenges faced by young women carrying hereditary breast and ovarian cancer (HBOC) genetic variants, many of whom are diagnosed at an early age. At the same time, the initiative also draws attention to the growing number of sporadic breast cancer cases in younger women, many of whom fall outside current screening programmes and are often diagnosed at later stages due to low awareness and limited early detection opportunities. By supporting the “2040 Initiative – First Circle BCYW Awareness” , EVITA aims to encourage continuous, everyday conversations about breast health, while also advocating for innovation and new technologies that could make earlier and more accessible screening possible for younger generations.

The president of EVITA, Tamara Milagre participated in the 2nd Oncology Nursing Meeting, held on 28 February 2026 at Hospital da Luz, Lisboa, Portugal. During her presentation on “Family Risk in Oncology,” she highlighted the importance of identifying people with a genetic predisposition to cancer and promoting an approach to oncology that focuses not only on treatment, but also on prevention. She also emphasized the importance of early detection and discussed recent technological advances linked to European research initiatives, including the MammoScreen Project.

On 11 April 2026, EVITA attended the 85th anniversary celebration of the Liga Portuguesa Contra o Cancro (the Portuguese Cancer League, LPCC). The commemorative event brought together healthcare professionals, institutional representatives, oncology partners, volunteers and policymakers to reflect on the past, present, and future of cancer care in Portugal. The ceremony included speeches from LPCC President and the presence of the Portuguese Minister for Health. EVITA congratulated the LPCC on this important milestone and reaffirmed its commitment to the shared mission of preventing cancer and caring for cancer patients.